Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification

Luca Laurenti; Idanna Innocenti; Francesco Autore; Stefania Ciolli; Francesca Romana Mauro; Donato Mannina; Giovanni Del Poeta; Giovanni D’Arena; Massimo Massaia; Marta Coscia; Stefano Molica; Gabriele Pozzato; Dimitar G. Efremov; Barbara Vannata; Roberto Marasca; Pietro Galieni; Antonio Cuneo; Sonia Orlando; Alfonso Piciocchi; Riccardo Boncompagni; Donatella Vincelli; Anna Marina Liberati; Filomena Russo; Robin Foa

doi:10.3324/haematol.2016.156901

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification

Luca Laurenti, Idanna Innocenti, Francesco Autore, Stefania Ciolli, Francesca Romana Mauro, Donato Mannina, Giovanni Del Poeta, Giovanni D’Arena, Massimo Massaia, Marta Coscia, Stefano Molica, Gabriele Pozzato, Dimitar G. Efremov, Barbara Vannata, Roberto Marasca, Pietro Galieni, Antonio Cuneo, Sonia Orlando, Alfonso Piciocchi, Riccardo BoncompagniDonatella Vincelli, Anna Marina Liberati, Filomena Russo, Robin Foa

IRCCS Centro di Riferimento Oncologico della Basilicata (CROB)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	352-355
Number of pages	4
Journal	Haematologica
Volume	102
Issue number	9
DOIs	https://doi.org/10.3324/haematol.2016.156901
Publication status	Published - Aug 31 2017

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2016.156901

Cite this

Laurenti, L., Innocenti, I., Autore, F., Ciolli, S., Mauro, F. R., Mannina, D., Del Poeta, G., D’Arena, G., Massaia, M., Coscia, M., Molica, S., Pozzato, G., Efremov, D. G., Vannata, B., Marasca, R., Galieni, P., Cuneo, A., Orlando, S., Piciocchi, A., ... Foa, R. (2017). Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification. Haematologica, 102(9), 352-355. https://doi.org/10.3324/haematol.2016.156901

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients : Correlation with biologically-based risk stratification. / Laurenti, Luca; Innocenti, Idanna; Autore, Francesco; Ciolli, Stefania; Mauro, Francesca Romana; Mannina, Donato; Del Poeta, Giovanni; D’Arena, Giovanni; Massaia, Massimo; Coscia, Marta; Molica, Stefano; Pozzato, Gabriele; Efremov, Dimitar G.; Vannata, Barbara; Marasca, Roberto; Galieni, Pietro; Cuneo, Antonio; Orlando, Sonia; Piciocchi, Alfonso; Boncompagni, Riccardo; Vincelli, Donatella; Liberati, Anna Marina; Russo, Filomena; Foa, Robin.

In: Haematologica, Vol. 102, No. 9, 31.08.2017, p. 352-355.

Research output: Contribution to journal › Letter › peer-review

Laurenti, L, Innocenti, I, Autore, F, Ciolli, S, Mauro, FR, Mannina, D, Del Poeta, G, D’Arena, G, Massaia, M, Coscia, M, Molica, S, Pozzato, G, Efremov, DG, Vannata, B, Marasca, R, Galieni, P, Cuneo, A, Orlando, S, Piciocchi, A, Boncompagni, R, Vincelli, D, Liberati, AM, Russo, F & Foa, R 2017, 'Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification', Haematologica, vol. 102, no. 9, pp. 352-355. https://doi.org/10.3324/haematol.2016.156901

Laurenti, Luca ; Innocenti, Idanna ; Autore, Francesco ; Ciolli, Stefania ; Mauro, Francesca Romana ; Mannina, Donato ; Del Poeta, Giovanni ; D’Arena, Giovanni ; Massaia, Massimo ; Coscia, Marta ; Molica, Stefano ; Pozzato, Gabriele ; Efremov, Dimitar G. ; Vannata, Barbara ; Marasca, Roberto ; Galieni, Pietro ; Cuneo, Antonio ; Orlando, Sonia ; Piciocchi, Alfonso ; Boncompagni, Riccardo ; Vincelli, Donatella ; Liberati, Anna Marina ; Russo, Filomena ; Foa, Robin. / Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients : Correlation with biologically-based risk stratification. In: Haematologica. 2017 ; Vol. 102, No. 9. pp. 352-355.

@article{2abf7f41bc864f509da3f3d637c21e0a,

title = "Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification",

author = "Luca Laurenti and Idanna Innocenti and Francesco Autore and Stefania Ciolli and Mauro, {Francesca Romana} and Donato Mannina and {Del Poeta}, Giovanni and Giovanni D{\textquoteright}Arena and Massimo Massaia and Marta Coscia and Stefano Molica and Gabriele Pozzato and Efremov, {Dimitar G.} and Barbara Vannata and Roberto Marasca and Pietro Galieni and Antonio Cuneo and Sonia Orlando and Alfonso Piciocchi and Riccardo Boncompagni and Donatella Vincelli and Liberati, {Anna Marina} and Filomena Russo and Robin Foa",

year = "2017",

month = aug,

day = "31",

doi = "10.3324/haematol.2016.156901",

language = "English",

volume = "102",

pages = "352--355",

journal = "Haematologica",

issn = "0390-6078",

publisher = "NLM (Medline)",

number = "9",

}

TY - JOUR

T1 - Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients

T2 - Correlation with biologically-based risk stratification

AU - Laurenti, Luca

AU - Innocenti, Idanna

AU - Autore, Francesco

AU - Ciolli, Stefania

AU - Mauro, Francesca Romana

AU - Mannina, Donato

AU - Del Poeta, Giovanni

AU - D’Arena, Giovanni

AU - Massaia, Massimo

AU - Coscia, Marta

AU - Molica, Stefano

AU - Pozzato, Gabriele

AU - Efremov, Dimitar G.

AU - Vannata, Barbara

AU - Marasca, Roberto

AU - Galieni, Pietro

AU - Cuneo, Antonio

AU - Orlando, Sonia

AU - Piciocchi, Alfonso

AU - Boncompagni, Riccardo

AU - Vincelli, Donatella

AU - Liberati, Anna Marina

AU - Russo, Filomena

AU - Foa, Robin

PY - 2017/8/31

Y1 - 2017/8/31

UR - http://www.scopus.com/inward/record.url?scp=85029578907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029578907&partnerID=8YFLogxK

U2 - 10.3324/haematol.2016.156901

DO - 10.3324/haematol.2016.156901

M3 - Letter

AN - SCOPUS:85029578907

VL - 102

SP - 352

EP - 355

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 9

ER -